PARP inhibition protects mitochondria and reduces ROS production

Potential mechanism of ROS-PARP-1-RelA signaling of cytokine

Elesclomol, a copper-transporting therapeutic agent targeting

Effect of ATF4/CREB2 silencing and PARP inhibition on mitochondrial ROS

Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS

Frontiers PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells

Poly(ADP-ribose) polymerase (PARP)-1-independent apoptosis-inducing factor (AIF) release and cell death are induced by eleostearic acid and blocked by alpha-tocopherol and MEK inhibition. - Abstract - Europe PMC

POR Recent advances and future directions in etiopathogenesis

ROS‐Mediated PARP Activity Undermines Mitochondrial Function After

Olaparib: A Clinically Applied PARP Inhibitor Protects from

PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage

Journal of Cellular Biochemistry

Mitochondrial PARP1 regulates NAD+-dependent poly ADP-ribosylation of mitochondrial nucleoids

Mechanism research and treatment progress of NAD pathway related molecules in tumor immune microenvironment, Cancer Cell International

ROS in cancer therapy: the bright side of the moon